Galectin Therapeutics, Inc. (GALT)
2.74
-0.02
(-0.72%)
USD |
NASDAQ |
Feb 17, 16:00
2.75
+0.01
(+0.36%)
Pre-Market: 20:00
Galectin Therapeutics Shareholders Equity (Quarterly) : -123.58M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Imunon, Inc. | 4.082M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.86M |
| Total Liabilities (Quarterly) | 136.44M |
| Debt to Equity Ratio | -0.9897 |
| Current Ratio | 0.0933 |
| Net Debt Paydown Yield | -2.11% |